Entity Common Stock, Shares Outstanding of Inozyme Pharma, Inc. from 31 Aug 2020 to 03 Mar 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Inozyme Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Aug 2020 to 03 Mar 2025.
  • Inozyme Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 03 Mar 2025 was 64,240,198, a 3.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Inozyme Pharma, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 64,240,198 +2,384,689 +3.9% 03 Mar 2025 10-K 10 Mar 2025 2024 FY
Q3 2024 64,240,198 +2,479,450 +4% 29 Oct 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 62,734,395 +1,004,729 +1.6% 30 Jul 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 61,855,509 +18,135,502 +41% 02 May 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 61,760,748 +21,366,385 +53% 01 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 61,729,666 +21,583,992 +54% 03 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 43,720,007 +20,047,441 +85% 17 Mar 2023 10-K 22 Mar 2023 2022 FY
Q3 2022 40,394,363 +16,729,616 +71% 07 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 40,145,674 +16,484,074 +70% 10 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 23,672,566 +208,436 +0.89% 10 Mar 2022 10-K/A 31 Mar 2022 2021 FY
Q3 2021 23,664,747 +299,896 +1.3% 08 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 23,661,600 06 Aug 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 23,464,130 19 Mar 2021 10-K 25 Mar 2021 2020 FY
Q3 2020 23,364,851 31 Aug 2020 10-Q 03 Sep 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.